Serum Anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles

• DOI: 10.1007/s10815-012-9754-6
• Publication Date: 2012-04-10T12:49:56Z
• Authors: Sezai Sahmay; Gökhan Demirayak; Onur Guralp; Pelin Ocal; Levent M. Senturk; Engin Oral; Tulay Irez
• Keywords: Adult; Anti-Mullerian Hormone; Estradiol; Pregnancy Rate; Thyrotropin; Fertilization in Vitro; Luteinizing Hormone; Prolactin; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Ovarian Follicle; Pregnancy; Humans; Female; Inhibins; Sperm Injections, Intracytoplasmic; Follicle Stimulating Hormone

To investigate whether serum anti-müllerian hormone (AMH), follicle stimulating hormone (FSH), or antral follicle count (AFC) are predictive for clinical pregnancy in in vitro fertilization (IVF) patients.Serum AMH, inhibin B, FSH, luteinizing hormone (LH), estradiol (E2), prolactin, and thyroid stimulating hormone (TSH) levels and AFC of 189 women under 40 years of age were investigated. Pregnant and non-pregnant women were compared.Forty-seven (24.8 %) clinical pregnancies were observed in 189 women. There was no significant difference in terms of mean age, duration of infertility, body mass index, AMH, LH, FSH, E2, TSH, Inhibin B, AFC and total oocyte number between women who did and who did not become pregnant. Additionally, there was no significant difference in clinical pregnancy rates between the quartiles of AMH, FSH and AFC. (P values were 0.668, 0.071, and 0.252, respectively.)Serum AMH and FSH, and AFC cannot predict clinical pregnancy in IVF patients under 40; the pregnancy rate tends to increase as AMH increases, although this remains non-significant.